Novartis continues strong momentum of sales growth with margin expansion, reaches key innovation milestones in 2024. Novartis ...

An expert approach to security selection is crucial in the high-yield market, where the asymmetrical return profiles of securities demands exceptional judgment and risk management. J.P. Morgan's team ...

By the beginning of 2025, it was clear the GLP-1 drugs were going to remain a major part of the industry. Pfizer used its presentation at the 43 rd JP Morgan Healthcre Conference to detail plans to ...

This year marks the flagship report's 30th anniversary, showcasing J.P. Morgan's (JPM) long-standing market expertise and leading research capabilities NEW YORK, Oct. 20, 2025 /PRNewswire/ -- J.P.

With a brand new 25-basis point rate cut now in the mix, high-yield dividend stocks could outperform into 2026. The question for growth and income investors now is whether President Trump’s next Fed ...

J.P. Morgan recently released their mid-year stock market predictions, giving an expected outlook for the rest of 2025. In general, expectations are tempered for growth, with Morgan predicting a ...